Albireo Pharma Inc (NASDAQ:ALBO)

33.49
Delayed Data
As of Jun 19
 +0.06 / +0.18%
Today’s Change
15.31
Today|||52-Week Range
39.87
+30.82%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Astrazeneca Plc
Sale12/01/2017500,000$21.40$10.7M+37.31%
Perceptive Advisors Llc
Buy1/25/2018275,000$33.00$9.1M-1.50%
Phase4 Ventures Ltd
Sale1/30/201898,500$34.40$3.4M-5.64%
Mattsson Jan Peter
Chief Operating Officer
Sale6/12/201815,676$32.19$504.6K+4.66%
Mattsson Jan Peter
Chief Operating Officer
Sale6/13/20186,903$32.08$221.4K+3.33%
Mattsson Jan Peter
Chief Operating Officer
Sale6/12/20182,421$33.23$80.4K+4.66%
Phase4 Ventures Ltd
Sale1/30/20181,500$37.06$55.6K-5.64%
Brown Julia R
Director
Buy6/07/20183,000$17.05$51.2K+7.79%
Brown Julia R
Director
Buy6/07/20181,500$18.54$27.8K+7.79%